Arch Therapeutic Ordinary (ARTH)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

235 WALNUT STREET, SUITE 6 FRAMINGHAM, MA 01702

Arch Therapeutics, Inc. operates as a life science company developing liquid polymers containing tiny peptides intended to form gel-like barriers over surgical wounds to stop or control bleeding.

Data as of 2021-07-19 09:06:26 -0400
Market Cap17.424 Million Shares Outstanding193.595 Million Avg 30-day Volume430.577 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low0.227 / 0.0706 Next Earnings Date2021-07-22 Price to Cash FLow (P/CF) -12.5369
Data provided by IEX Cloud
View SEC Filings from ARTH instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 3 2 50.0% (0.0%) (0.0%)
13F shares: 81 Thousand 69.5 Thousand 16.55%
% Ownership 0.0418 0.036 16.11%
New Positions: 1
Increased Positions
Closed Positions 1
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ARTH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ARTH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ABRAMS MICHAEL S CFO AND TREASURER

  • Officer
0 2021-05-10 1

SULAT JAMES R

  • Director
1,746,813 2020-06-22 0

NORCHI TERRENCE W PRESIDENT & CEO

  • Officer
  • Director
0 2019-12-20 0

DAVIS RICHARD E CFO & TREASURER

  • Officer
0 2019-12-20 0

DHILLON PUNIT

  • Director
0 2019-12-20 0

DHILLON AVTAR S

  • Director
No longer subject to file 2018-07-19 0

ROSENTHAL ARTHUR L

  • Director
0 2015-01-22 0

COTTER WILLIAM M CHIEF OPERATING OFFICER

  • Officer
0 2014-03-23 0

BARBER ALAN CHIEF FINANCIAL OFFICER

  • Officer
0 2013-09-09 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ARCH THERAPEUTICS INC ARTH 2021-07-23 22:15:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 21:45:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 21:15:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 20:45:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 20:15:05 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 19:45:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 19:15:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 18:45:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 18:15:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 17:45:03 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 17:15:02 UTC -3.9364 4.0164 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 16:45:02 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 16:15:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 15:45:02 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 15:15:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 14:45:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 14:15:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 13:45:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 13:15:03 UTC -3.9409 4.0209 3700000
ARCH THERAPEUTICS INC ARTH 2021-07-23 12:45:03 UTC -3.9409 4.0209 3700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments